Skip navigation
Skip navigation

Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility

Wirasinha, Rushika C.; Davies, Ainsley; Srivastava, Monika; Sheridan, Julie M.; Sng, Xavier Y. X.; Delmonte, Ottavia M.; Dobbs, Kerry; Loh, Khai L.; Miosge, Lisa; Lee, Cindy; Chand, Rochna; Chan, Anna; Yap, Jin Yan; Keller, Michael D.; Chen, Karin; Rossjohn, J.; La Gruta, Nicole L.; Vinuesa, Carola; Reid, Hugh H.; Lionakis, Michail S.; Notarangelo, Luigi D.; Gray, Daniel H. D.; Goodnow, Christopher C.; Cook, Matthew; Daley, Stephen


NF-κB2/p100 (p100) is an inhibitor of κB (IκB) protein that is partially degraded to produce the NF-κB2/p52 (p52) transcription factor. Heterozygous NFKB2 mutations cause a human syndrome of immunodeficiency and autoimmunity, but whether autoimmunity arises from insufficiency of p52 or IκB function of mutated p100 is unclear. Here, we studied mice bearing mutations in the p100 degron, a domain that harbors most of the clinically recognized mutations and is required for signal-dependent p100...[Show more]

CollectionsANU Research Publications
Date published: 2020-10-27
Type: Journal article
Source: Journal of Experimental Medicine
DOI: 10.1084/jem.20200476
Access Rights: Open Access


File Description SizeFormat Image
01_Wirasinha_Nfkb2_variants_reveal_a_2020.pdf7.66 MBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator